Galectin-9 通过与 CD44 相互作用促进 NK 细胞活性

Natural killer (NK) cells are a potent innate source of cytokines and cytoplasmic granules. Their effector functions are tightly synchronized by the balance between the stimulatory and inhibitory receptors.

Here, we quantified the proportion of NK cells and the surface presence of Galectin-9 (Gal-9) from the bone marrow, blood, liver, spleen, and lungs of adult and neonatal mice.

We also examined the effector functions of Gal-9 + NK cells compared with their Gal-9 - counterparts.

Our results revealed that Gal-9 + NK cells are more abundant in tissues, in particular, in the liver than in the blood and bone marrow.

We found Gal-9 presence was associated with enhanced cytotoxic effector molecules granzyme B (GzmB) and perforin expression. Likewise, Gal-9 expressing NK cells displayed greater IFN-γ and TNF-α expression than their negative counterparts under hemostatic circumstances.

Notably, the expansion of Gal-9 + NK cells in the spleen of mice infected with E. coli implies that Gal-9 + NK cells may provide a protective role against infection. Similarly, we found the expansion of Gal-9 + NK cells in the spleen and tumor tissues of melanoma B16-F10 mice.

Mechanistically, our results revealed the interaction of Gal-9 with CD44 as noted by their co-expression/co-localization. Subsequently, this interaction resulted in enhanced expression of Phospho-LCK, ERK, Akt, MAPK, and mTOR in NK cells.

Moreover, we found Gal-9 + NK cells exhibited an activated phenotype as evidenced by increased CD69, CD25, and Sca-1 but reduced KLRG1 expression. Likewise, we found Gal-9 preferentially interacts with CD44 high in human NK cells. Despite this interaction, we noted a dichotomy in terms of effector functions in NK cells from COVID-19 patients. We observed that the presence of Gal-9 on NK cells resulted in a greater IFN-γ expression without any changes in cytolytic molecule expression in these patients.

These observations suggest differences in Gal-9 + NK cell effector functions between mice and humans that should be considered in different physiological and pathological conditions. Therefore, our results highlight the important role of Gal-9 via CD44 in NK cell activation, which suggests Gal-9 is a potential new avenue for the development of therapeutic approaches to modulate NK cell effector functions.